PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: PharmaZell

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PharmaZell Continues Expansion of Pharmaceutical Manufacturing Capacity in India - PharmaZell GmbH, a European Contract Manufacturing Organization for active pharmaceutical ingredients and advanced intermediates, has once again expanded its manufacturing capabilities in India
PharmaZell Continues Expansion of Pharmaceutical Manufacturing Capacity in India

 

NewswireToday - /newswire/ - Cleveland, OH, United States, 2010/09/20 - PharmaZell GmbH, a European Contract Manufacturing Organization for active pharmaceutical ingredients and advanced intermediates, has once again expanded its manufacturing capabilities in India.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In 2010, PharmaZell completed construction of a cGMP Kilo-lab at its R&D center in Vizag, India. This follows two other recent expansions in India. In 2007, PharmaZell built a commercial production plant in Vizag, India to produce the active pharmaceutical ingredient, Mesalamine. In 2008, PharmaZell continued expanding in Vizag by building a state of the art R&D facility. This facility employs approximately 35 chemists who focus on chemical route and process development, analytical R&D and small scale synthesis.

In 2007, PharmaZell expanded its European base by acquiring a fully integrated development and commercial production site from Sandoz in Copenhagen, Denmark. The site in Denmark has a particular focus on controlled substances. Its scientists there have expertise in lab development, pilot plant and commercial manufacturing under cGMP. “In the past three years PharmaZell has had three expansions in India while growing by acquisition in Europe. We have continued to grow our manufacturing capacity and expand our services to the pharmaceutical and biotechnology industries. We believe that our strong revenue growth and diverse customer base is positioning our company as a significant API manufacturer and service provider” said Wolfgang Burger, Ph.D., Managing Partner of PharmaZell.

About PharmaZell

PharmaZell (pharmaceuticalonline.com) is a European Contract Manufacturing Organization (CMO) that provides products and services to the pharmaceutical and biotech industries. PharmaZell performs custom synthesis and manufacturing of small molecule drug substances and advanced intermediates at the gram, kilogram and metric ton scales. The company provides a broad range of capabilities in chemistry, process research and development, process optimization, scale-up and commercialization as well comprehensive analytical and regulatory services for active pharmaceutical ingredients (APIs) in support of preclinical programs, clinical trials, and commercial production. PharmaZell also offers a diverse product portfolio of APIs and amino acids to the pharmaceutical, nutraceutical and food industries.

PharmaZell was founded in 1947 and was successfully spun off from Noveon/Lubrizol in 2006, through a management buyout. The company is headquartered in Raubling, Germany which is near the Munich area. A second production site was built in 1994 in Chennai, India, followed by expansions in Copenhagen, Denmark and Vizag India in 2007. PharmaZell has 500 employees located at the four sites in Europe and India. All four sites are fully compliant with current GMP regulations. The sites in Germany and Chennai have been inspected by the FDA and inspections of the sites in Copenhagen and Vizag, India are expected within the coming months.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PharmaZell

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


PharmaZell Continues Expansion of Pharmaceutical Manufacturing Capacity in India

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: George Hlass - PharmaZell.com 
919-786-6858 george.hlass[.]pharmazell.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PharmaZell securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PharmaZell / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Deb Sheppard - Medium Psychic Author Speaker





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)